SCHEMBL992208

SCHEMBL992208

O=C(c1cc(Br)ccn1)N(c1ccccc1)c1cccc(-c2nncn2C2CC2)c1

nearest known ligand 0.44

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ MAP3K5 Q99683 14/20 0.44
▸ MYLK Q15746 3/20 0.35
▸ TNF P01375 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ CHRM2 P08172 2/20 0.34
▸ CHRM1 P11229 2/20 0.34
▸ CHRM3 P20309 2/20 0.34
▸ AGTR2 P50052 1/20 0.34
▸ CHRM4 P08173 1/20 0.33
▸ CHRM5 P08912 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22711043 0.85 MAP3K5 (0.43) MAP3K5MYLKTNFAGTR2
SCHEMBL20473178 0.84 MAP3K5 (0.41) MAP3K5MYLKTNF
SCHEMBL20473179 0.82 MAP3K5 (0.40) MAP3K5MYLKTNF
SCHEMBL993194 0.79 MAP3K5 (0.45) MAP3K5MYLKTNF
SCHEMBL945572 0.78 MAP3K5 (0.68) MAP3K5MYLKSMN1; SMN2
SCHEMBL16354007 0.78 NPC1 (0.41) MAP3K5MYLKTNFSMN1; SMN2
SCHEMBL943988 0.71 MAP3K5 (0.69) MAP3K5MYLKSMN1; SMN2
SCHEMBL952626 0.69 MAP3K5 (0.67) MAP3K5SMN1; SMN2
SCHEMBL10220980 0.67 MAP3K5 (0.40) MAP3K5TNFKDM4EALDH1A1SMN1; SMN2
SCHEMBL235196 0.67 MAP3K5 (0.48) MAP3K5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2454250-A1 APOPTOSIS SIGNAL-REGULATING KINASE INHIBITORS Gilead Sciences, Inc. (US) 2012-05-23 — — EP disclosed
WO-2011008709-A1 APOPTOSIS SIGNAL-REGULATING KINASE INHIBITORS GILEAD SCIENCES, INC. (US) 2011-01-20 — — WO disclosed
Send feedback